Cocrystal Net Invested Capital vs Intangible Assets Analysis

COCP Stock

USD 1.56 0.05 3.31%

Cocrystal Pharma financial indicator trend analysis is way more than just evaluating Cocrystal Pharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cocrystal Pharma is a good investment. Please check the relationship between Cocrystal Pharma Net Invested Capital and its Intangible Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Net Invested Capital vs Intangible Assets

Net Invested Capital vs Intangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cocrystal Pharma Net Invested Capital account and Intangible Assets. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Cocrystal Pharma's Net Invested Capital and Intangible Assets is 0.15. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Cocrystal Pharma, assuming nothing else is changed. The correlation between historical values of Cocrystal Pharma's Net Invested Capital and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Cocrystal Pharma are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Net Invested Capital i.e., Cocrystal Pharma's Net Invested Capital and Intangible Assets go up and down completely randomly.

Correlation Coefficient

0.15

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Most indicators from Cocrystal Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cocrystal Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.At this time, Cocrystal Pharma's Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 04/28/2024, Enterprise Value Multiple is likely to grow to 0.37, while Selling General Administrative is likely to drop 5,690.

	2023	2024 (projected)
Non Recurring	41.5M	36.9M
Reconciled Depreciation	412K	302.2K

Non Recurring Reconciled Depreciation

Cocrystal Pharma fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Other Current Liab	Property Plant And Equipment Net	Other Current Assets	Property Plant And Equipment Gross	Short Long Term Debt Total	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Short Term Debt
Total Assets		0.17	0.58	0.03	0.2	0.24	-0.08	0.69	0.59	-0.06	0.55	-0.09	-0.16	0.77	-0.1	0.57	0.3	-0.46	-0.28	-0.46	-0.43	-0.14	0.68	0.41	-0.45	0.34
Total Current Liabilities	0.17		-0.32	0.43	0.6	0.06	-0.41	0.64	0.75	-0.4	0.11	-0.37	-0.65	0.45	-0.35	0.14	0.86	0.22	0.49	0.01	0.16	-0.36	0.29	0.77	0.12	0.84
Total Stockholder Equity	0.58	-0.32		-0.21	-0.22	0.49	0.17	0.26	0.08	0.16	0.68	0.14	0.53	-0.06	0.13	0.68	-0.24	-0.41	-0.26	-0.32	-0.51	0.12	0.5	-0.26	-0.51	-0.31
Net Debt	0.03	0.43	-0.21		0.75	0.05	-0.99	0.33	0.22	-0.99	0.09	-0.8	-0.66	0.19	-0.99	0.13	0.29	0.06	-0.08	-0.33	0.48	0.32	0.33	0.26	0.44	0.48
Retained Earnings	0.2	0.6	-0.22	0.75		-0.08	-0.75	0.48	0.48	-0.74	0.13	-0.51	-0.9	0.39	-0.74	0.23	0.47	-0.03	-0.04	-0.4	0.6	-0.17	0.31	0.47	0.6	0.77
Accounts Payable	0.24	0.06	0.49	0.05	-0.08		-0.02	-0.02	0.09	-0.03	0.41	-0.05	0.28	-0.09	-0.04	0.39	-0.17	0.32	-0.28	0.24	-0.01	-0.07	-0.03	-0.32	-0.05	-0.2
Cash	-0.08	-0.41	0.17	-0.99	-0.75	-0.02		-0.4	-0.27	1.0	-0.12	0.8	0.65	-0.22	1.0	-0.17	-0.32	0.05	0.06	0.43	-0.42	-0.31	-0.41	-0.31	-0.38	-0.5
Non Current Assets Total	0.69	0.64	0.26	0.33	0.48	-0.02	-0.4		0.9	-0.38	0.44	-0.32	-0.43	0.64	-0.37	0.49	0.83	-0.53	0.36	-0.62	-0.36	-0.24	0.86	0.85	-0.4	0.78
Non Currrent Assets Other	0.59	0.75	0.08	0.22	0.48	0.09	-0.27	0.9		-0.26	0.35	-0.27	-0.49	0.65	-0.24	0.37	0.88	-0.36	0.43	-0.42	-0.23	-0.53	0.59	0.87	-0.27	0.86
Cash And Short Term Investments	-0.06	-0.4	0.16	-0.99	-0.74	-0.03	1.0	-0.38	-0.26		-0.12	0.8	0.64	-0.19	1.0	-0.17	-0.31	0.05	0.05	0.42	-0.42	-0.32	-0.4	-0.29	-0.39	-0.49
Common Stock Total Equity	0.55	0.11	0.68	0.09	0.13	0.41	-0.12	0.44	0.35	-0.12		-0.19	0.12	0.15	-0.13	0.98	0.15	-0.23	-0.04	-0.25	-0.23	0.11	0.46	0.07	-0.27	0.12
Common Stock Shares Outstanding	-0.09	-0.37	0.14	-0.8	-0.51	-0.05	0.8	-0.32	-0.27	0.8	-0.19		0.46	-0.22	0.78	-0.15	-0.34	0.0	-0.12	0.15	-0.34	-0.4	-0.24	-0.27	-0.28	-0.42
Other Stockholder Equity	-0.16	-0.65	0.53	-0.66	-0.9	0.28	0.65	-0.43	-0.49	0.64	0.12	0.46		-0.59	0.64	0.04	-0.56	-0.04	-0.01	0.28	-0.56	0.24	-0.18	-0.62	-0.55	-0.84
Total Liab	0.77	0.45	-0.06	0.19	0.39	-0.09	-0.22	0.64	0.65	-0.19	0.15	-0.22	-0.59		-0.21	0.17	0.55	-0.23	-0.14	-0.29	-0.14	-0.26	0.43	0.7	-0.17	0.65
Total Current Assets	-0.1	-0.35	0.13	-0.99	-0.74	-0.04	1.0	-0.37	-0.24	1.0	-0.13	0.78	0.64	-0.21		-0.18	-0.26	0.07	0.13	0.45	-0.42	-0.31	-0.41	-0.26	-0.39	-0.46
Common Stock	0.57	0.14	0.68	0.13	0.23	0.39	-0.17	0.49	0.37	-0.17	0.98	-0.15	0.04	0.17	-0.18		0.16	-0.28	-0.07	-0.36	-0.2	0.06	0.53	0.1	-0.23	0.17
Other Current Liab	0.3	0.86	-0.24	0.29	0.47	-0.17	-0.32	0.83	0.88	-0.31	0.15	-0.34	-0.56	0.55	-0.26	0.16		-0.2	0.67	-0.26	-0.13	-0.38	0.49	0.96	-0.19	0.9
Property Plant And Equipment Net	-0.46	0.22	-0.41	0.06	-0.03	0.32	0.05	-0.53	-0.36	0.05	-0.23	0.0	-0.04	-0.23	0.07	-0.28	-0.2		-0.15	0.87	0.54	0.07	-0.66	-0.34	0.51	-0.19
Other Current Assets	-0.28	0.49	-0.26	-0.08	-0.04	-0.28	0.06	0.36	0.43	0.05	-0.04	-0.12	-0.01	-0.14	0.13	-0.07	0.67	-0.15		-0.01	-0.25	-0.19	0.13	0.54	-0.28	0.4
Property Plant And Equipment Gross	-0.46	0.01	-0.32	-0.33	-0.4	0.24	0.43	-0.62	-0.42	0.42	-0.25	0.15	0.28	-0.29	0.45	-0.36	-0.26	0.87	-0.01		0.28	0.04	-0.76	-0.4	0.23	-0.38
Short Long Term Debt Total	-0.43	0.16	-0.51	0.48	0.6	-0.01	-0.42	-0.36	-0.23	-0.42	-0.23	-0.34	-0.56	-0.14	-0.42	-0.2	-0.13	0.54	-0.25	0.28		0.03	-0.51	-0.2	0.98	0.18
Net Receivables	-0.14	-0.36	0.12	0.32	-0.17	-0.07	-0.31	-0.24	-0.53	-0.32	0.11	-0.4	0.24	-0.26	-0.31	0.06	-0.38	0.07	-0.19	0.04	0.03		0.02	-0.38	-0.02	-0.42
Good Will	0.68	0.29	0.5	0.33	0.31	-0.03	-0.41	0.86	0.59	-0.4	0.46	-0.24	-0.18	0.43	-0.41	0.53	0.49	-0.66	0.13	-0.76	-0.51	0.02		0.55	-0.51	0.43
Non Current Liabilities Total	0.41	0.77	-0.26	0.26	0.47	-0.32	-0.31	0.85	0.87	-0.29	0.07	-0.27	-0.62	0.7	-0.26	0.1	0.96	-0.34	0.54	-0.4	-0.2	-0.38	0.55		-0.23	0.91
Inventory	-0.45	0.12	-0.51	0.44	0.6	-0.05	-0.38	-0.4	-0.27	-0.39	-0.27	-0.28	-0.55	-0.17	-0.39	-0.23	-0.19	0.51	-0.28	0.23	0.98	-0.02	-0.51	-0.23		0.15
Short Term Debt	0.34	0.84	-0.31	0.48	0.77	-0.2	-0.5	0.78	0.86	-0.49	0.12	-0.42	-0.84	0.65	-0.46	0.17	0.9	-0.19	0.4	-0.38	0.18	-0.42	0.43	0.91	0.15

Click cells to compare fundamentals

Cocrystal Pharma Account Relationship Matchups

Cocrystal Pharma fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	28.5M	54.2M	79.4M	40.8M	31.3M	29.7M
Total Current Liabilities	2.3M	1.4M	1.5M	1.2M	3.3M	2.7M
Total Stockholder Equity	25.7M	52.5M	77.5M	39.6M	26.4M	42.6M
Net Debt	(6.6M)	(32.4M)	(58.2M)	(36.8M)	(24.6M)	(23.3M)
Retained Earnings	(235.3M)	(244.9M)	(259.1M)	(297.9M)	(315.9M)	(300.1M)
Accounts Payable	1.5M	657K	578K	614K	1.2M	937.8K
Cash	7.4M	33.0M	58.7M	37.1M	26.4M	27.7M
Non Current Assets Total	20.3M	20.2M	20.1M	662K	2.2M	2.1M
Cash And Short Term Investments	7.4M	33.0M	58.7M	37.1M	26.4M	27.7M
Common Stock Total Equity	24K	30K	36K	71K	81.7K	152.4K
Common Stock Shares Outstanding	31.9M	55.2M	88.4M	8.1M	9.7M	13.1M
Liabilities And Stockholders Equity	28.5M	54.2M	79.4M	40.8M	31.3M	29.7M
Other Stockholder Equity	260.9M	297.3M	336.5M	337.5M	342.3M	359.4M
Total Liab	2.8M	1.7M	1.8M	1.3M	4.9M	4.6M
Total Current Assets	8.3M	34.0M	59.3M	40.2M	29.1M	30.5M
Common Stock	36K	71K	98K	8K	10K	9.5K
Other Current Liab	7K	61K	12K	362K	1.8M	1.7M
Property Plant And Equipment Net	1.1M	1.1M	931K	616K	2.1M	2.2M
Other Current Assets	169K	399K	568K	2.2M	1.8M	930.3K
Property Plant And Equipment Gross	1.1M	1.1M	2.4M	2.2M	3.9M	4.1M
Short Long Term Debt Total	817K	596K	534K	297K	1.9M	1.6M
Non Current Liabilities Total	537K	379K	298K	57K	1.6M	1.5M
Short Term Debt	280K	217K	236K	240K	216K	205.2K
Net Tangible Assets	6.6M	33.4M	58.5M	39.6M	35.6M	34.6M
Retained Earnings Total Equity	(138.0M)	(187.1M)	(235.3M)	(244.9M)	(220.4M)	(209.4M)
Capital Surpluse	243.4M	253.9M	260.9M	297.3M	341.9M	215.9M
Other Assets	50K	544K	46K	0.0	1.0	0.95
Property Plant Equipment	1.1M	1.1M	931K	616K	708.4K	640.6K
Net Invested Capital	25.7M	52.5M	77.5M	39.6M	26.4M	45.1M

Pair Trading with Cocrystal Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Cocrystal Stock

0.54	KYMR	Kymera Therapeutics Financial Report 2nd of May 2024	Pair Corr
0.51	CCCC	C4 TherapeuticsInc Financial Report 2nd of May 2024	Pair Corr
0.5	FHTX	Foghorn TherapeuticsInc Financial Report 13th of May 2024	Pair Corr
0.45	HCWB	HCW Biologics	Pair Corr
0.44	BEAM	Beam TherapeuticsInc Financial Report 8th of May 2024	Pair Corr

The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.

The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Cocrystal Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cocrystal Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cocrystal Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Cocrystal Pharma Stock:

How To Invest In Cocrystal

Details

Is Cocrystal Stock a good investment?

Details

What is Cocrystal Pharma's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Note that the Cocrystal Pharma information on this page should be used as a complementary analysis to other Cocrystal Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Cocrystal Stock analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.

	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Global Correlations Find global opportunities by holding instruments from different markets
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio

Is Cocrystal Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cocrystal Pharma. If investors know Cocrystal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cocrystal Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.87)

Revenue Per Share

0.006

Quarterly Revenue Growth

0.269

Return On Assets

(0.37)

Return On Equity

(0.55)

The market value of Cocrystal Pharma is measured differently than its book value, which is the value of Cocrystal that is recorded on the company's balance sheet. Investors also form their own opinion of Cocrystal Pharma's value that differs from its market value or its book value, called intrinsic value, which is Cocrystal Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cocrystal Pharma's market value can be influenced by many factors that don't directly affect Cocrystal Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cocrystal Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cocrystal Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cocrystal Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cocrystal Net Invested Capital vs Intangible Assets Analysis

Net Invested Capital vs Intangible Assets

Net Invested Capital vs Intangible Assets Correlation Analysis

Correlation Coefficient

Net Invested Capital

Intangible Assets

Cocrystal Pharma fundamental ratios Correlations

Cocrystal Pharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cocrystal Pharma fundamental ratios Accounts

Pair Trading with Cocrystal Pharma

Moving against Cocrystal Stock

Complementary Tools for Cocrystal Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 0.98	Common Stock Total Equity
Inventory	+ 0.98	Short Long Term Debt Total
Non Current Liabilities Total	+ 0.96	Other Current Liab

Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Other Stockholder Equity	- 0.9	Retained Earnings
Short Term Debt	- 0.84	Other Stockholder Equity
Common Stock Shares Outstanding	- 0.8	Net Debt